Financials

  • Market Capitalization 3.39 B
  • Employee 354
  • Founded 2016
  • CEO Frank Watanabe
  • Website www.arcutis.com
  • Headquarter Delaware, United States
  • FIGI BBG00QN8K4M4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-223.38
Price to sales ratio
9.82

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1584
RCUS
Arcus Biosciences, Inc. Common Stock
28.08 USD-2.90%-7.17%+15.03%+190.08%3.53 B USD
1600
ALMS
Alumis Inc. - Common Stock
28.10 USD-0.74%+1.52%+15.21%+523.06%3.47 B USD
1617
DYN
Dyne Therapeutics, Inc. - Common Stock
23.64 USD+0.94%+3.68%+28.06%+0.98%3.38 B USD
1621
ADPT
Adaptive Biotechnologies Corporation - Common Stock
21.02 USD-0.19%-1.64%+14.36%+21.78%3.36 B USD

Frequently asked questions about Arcutis Biotherapeutics, Inc. - Common stock

What is the Arcutis Biotherapeutics, Inc. - Common stock stock price today?

The current price of Arcutis Biotherapeutics, Inc. - Common stock (ARQT) is 27.12. Over the past 24 hours, the stock has changed by -2.24%. Follow the ARQT chart for real-time price dynamics.

What is the stock ticker of Arcutis Biotherapeutics, Inc. - Common stock?

Arcutis Biotherapeutics, Inc. - Common stock trades under the ticker ARQT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Arcutis Biotherapeutics, Inc. - Common stock stock going up?

ARQT has changed by +3.12% over the last week, +10.15% over the last month, and +70.14% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Arcutis Biotherapeutics, Inc. - Common stock net income for the last quarter?

Arcutis Biotherapeutics, Inc. - Common stock reported net income of -11.29 M for the last quarter. The previous quarter showed 17.39 M, which means net income changed by -164.93%.

How many employees does Arcutis Biotherapeutics, Inc. - Common stock have?

As of the latest available data, Arcutis Biotherapeutics, Inc. - Common stock has 354 employees. Workforce size can provide additional context about the company's scale and operations.

What is Arcutis Biotherapeutics, Inc. - Common stock EBITDA?

Arcutis Biotherapeutics, Inc. - Common stock EBITDA is -8.71 M, and its EBITDA margin is -8.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Arcutis Biotherapeutics, Inc. - Common stock stock?

You can buy Arcutis Biotherapeutics, Inc. - Common stock (ARQT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Arcutis Biotherapeutics, Inc. - Common stock stock?

Investing in Arcutis Biotherapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARQT chart and related analysis on metatrader.com as part of your research.

News